Testing a combined flu and COVID-19 mRNA vaccine in older adults
Part of Infections, Lungs & breathing clinical trials.
This trial is testing whether a new mRNA vaccine that targets both seasonal flu and COVID-19 is safe and creates a strong immune response. It may offer an easier way to protect against two illnesses with one shot.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 65 and 85 years old.
- You are generally healthy or have stable medical conditions that are well-managed.
- You have not had the flu or COVID-19 in the past 3 to 6 months.
- You have not had a serious allergic reaction to any flu or COVID-19 vaccine before.
- You have not received a flu or COVID-19 vaccine recently (within the past 3 to 6 months).
- You do not have a weakened immune system or a history of certain heart conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how your immune system (your body’s infection-fighting system) responds during and around the time of a flu illness. It’s meant to help researchers better understand immune changes in healthy adults and may guide future flu care.
This trial tests a single combined vaccine that protects against both influenza (flu) and COVID-19. It aims to see how well it works in adults aged 65 and older, potentially offering simpler protection with one shot.
This trial tests an experimental mRNA flu vaccine in healthy adults ages 18 to 59. Researchers want to see if it is safe and helps the body build protection against the flu.
This study tests a new investigational flu vaccine (FluMos-v2) with or without an adjuvant (ALFQ) to see how safe, tolerable, and effective it is. It may help protect against multiple flu strains.
This trial is testing a new mRNA-based flu vaccine in healthy adults. It aims to see if the vaccine is safe and effective at preventing influenza.
This study tests an experimental oral vaccine that may protect against both COVID-19 and the flu. Researchers want to see if it's safe and how the body responds.
Hear when a new Influenza, Human+COVID-19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.